Licorice extract and carbenoxolone protect PC۱۲ cells against serum/glucose deprivation-induced apoptosis through modulation of caspase-۳ and PARP activation
محل انتشار: مجله گیاهان دارویی ابن سینا، دوره: 15، شماره: 4
سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 152
فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_AJP-15-4_002
تاریخ نمایه سازی: 2 تیر 1404
چکیده مقاله:
Objective: Serum/glucose deprivation in cultured PC۱۲ cells is considered an appropriate model for investigating detailed mechanisms of ischemia-induced brain injury. Here, we aimed to study the anti-apoptotic effects of licorice (Glycyrrhiza glabra L.) root extract and carbenoxolone on PC۱۲ cells cultured in the serum/glucose deprivation (SGD) condition.Materials and Methods: Cells were incubated with the different concentrations of the G. glabra methanol extract (۵-۳۲۰ µg/ml) and carbenoxolone (۰.۵-۳۲ µM) for ۲ hr before being deprived of serum/glucose. Protection against cytotoxicity, increase in reactive oxygen species (ROS), and apoptosis was analyzed with resazurin, dichlorofluorescein diacetate (DCFH-DA), and western blot, respectively.Results: Serum/glucose deprivation induced cell death and apoptosis in PC۱۲ cells. Pretreatment with the G. glabra methanol extract at ۵-۲۰ µg/ml and carbenoxolone at ۰.۵-۲ µM for ۲ hr significantly decreased the cytotoxicity (p<۰.۰۵), and pretreatment with the G. glabra methanol extract (۵-۱۶۰ µg/ml) and carbenoxolone (۰.۵ μM) significantly decreased the ROS content. Pretreatment with the G. glabra methanol extract and carbenoxolone at ۵-۲۰ µg/ml significantly prevented from the Poly (ADP-ribose) polymerase (PARP) and caspase-۳ cleavage.Conclusion: Taken together, this study confirms the protective and free radical-scavenging potency of licorice extract and carbenoxolone in in vitro model of ischemia. Overall, it seems that pretreatment with the licorice extract and carbenoxolone may potentially slow the progression of brain ischemia.
کلیدواژه ها:
نویسندگان
Hossein Hosseinzadeh
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Elham Ramazani
Department of Biology, Faculty of Science, Yazd University, Yazd, Iran. Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Soheyla Bakhshi
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra Tayarani Najjaran
Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.